Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Mallinckrodt
Teva
Covington
McKinsey
US Department of Justice
Federal Trade Commission
Johnson and Johnson

Generated: May 26, 2018

DrugPatentWatch Database Preview

PENTOLAIR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Pentolair patents expire, and when can generic versions of Pentolair launch?

Pentolair is a drug marketed by Bausch And Lomb and Pharmafair and is included in three NDAs.

The generic ingredient in PENTOLAIR is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Drug patent expirations by year for PENTOLAIR
Medical Subject Heading (MeSH) Categories for PENTOLAIR
Synonyms for PENTOLAIR
(+-)-cyclopentolate HCl
(+/-)-Cyclopentolate Hydrochloride
2-(2-(1-Hydroxycyclopentyl)-2-phenylacetoxy)ethyldimethylammonium chloride
2-(Dimethylamino)ethyl (+-)-1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate hydrochloride
2-(Dimethylamino)ethyl 1-Hydroxy-|A-phenylcyclopentaneacetate Hydrochloride
2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate hydrochloride
2-(Dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;hydrochloride
2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
5870-29-1
870C291
AC-27486
AC1L2JUE
AK-Pentolate
AK144155
AKOS015901379
Akpentolate
Alnide
AN-20017
Benzeneacetic acid, ?-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, (+-)-
beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate hydrochloride
CAS-5870-29-1
CC0260
CCG-39635
CHEBI:4025
CHEMBL1200473
Ciclolux
Cicloplegicedol
Cyclogyl (TN)
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester,hydrochloride
Cyclopentolate for system suitability, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate HCL
CYCLOPENTOLATE HYDROCHLORIDE
Cyclopentolate hydrochloride (JP17/USP)
Cyclopentolate hydrochloride [USAN:JAN]
Cyclopentolate hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate hydrochloride, United States Pharmacopeia (USP) Reference Standard
Cyplegin
D01002
DSSTox_CID_25390
DSSTox_GSID_45390
DSSTox_RID_80847
DTXSID9045390
EINECS 227-521-8
FT-0603161
HMS1571K12
HMS1920A22
I14-15042
LS-57811
MFCD00079048
MLS000069583
MLS001148637
MLS001332539
MLS001332540
MolPort-003-666-151
Mydplegic
NCGC00016661-01
NCGC00018213-06
NCGC00094635-01
NCGC00094635-02
NCGC00094635-03
NCGC00094635-04
NSC-756706
NSC756706
Opera_ID_69
OR147284
Pharmakon1600-01500212
REGID_for_CID_22162
SC-81592
SCHEMBL24612
Skiacol
SMR000058810
SPECTRUM1500212
ST24039645
Tox21_110550
Tox21_110550_1
Y0424
Zyklolat

US Patents and Regulatory Information for PENTOLAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb PENTOLAIR cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 040075-001 Apr 29, 1994 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PENTOLAIR cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 088643-001 Feb 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PENTOLAIR cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 088150-001 Feb 25, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cipla
Federal Trade Commission
US Department of Justice
Dow
UBS
Queensland Health
US Army
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.